Combined with the antioxidant mechanisms mentioned above, SGLT2 inhibitors could disrupt the vicious cycle between insulin resistance and oxidative stress and are therefore an excellent therapeutic option. This evidence concerns the gene SLC5A2 and Insulin resistance.